ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Active ETF
    • Alternatives
    • Beyond Basic Beta
    • China Insights
    • Climate Insights
    • Commodities
    • Core Strategies
    • Crypto
    • Disruptive Technology
    • Dividend
    • Dual Impact
    • Emerging Markets
    • Energy Infrastructure
    • ESG
    • ETF Building Blocks
    • ETF Education
    • ETF Strategist
    • Fixed Income
    • Free Cash Flow
    • Future ETFs
    • Global Diversification
    • Gold/Silver/Critical Minerals
    • Innovative ETFs
    • Institutional Income Strategies
    • Leveraged & Inverse
    • Managed Futures
    • Market Insights
    • Megatrends
    • Modern Alpha
    • Multi-Asset
    • Night Effect
    • Portfolio Strategies
    • Retirement Income
    • Richard Bernstein Advisors
    • Tax Efficient Income
    • Thematic Investing
    • Volatility Resource
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
    • ETF Data for Journalists
    • ETF Nerds
  • Research
    • First Bitcoin ETF
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF Trends on Videos
    • ETF Trends on Podcasts
    • ETF Prime Podcast
  • Company
    • About Us
    • Swag Store
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Nasdaq Portfolio Solutions Channel
  2. Cap-Weighting Critical When Indexing Biotech
Nasdaq Portfolio Solutions Channel
Share

Cap-Weighting Critical When Indexing Biotech

James ComtoisJan 25, 2022
2022-01-25

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don’t yet have steady revenue streams because their new drug or treatment is still in development, hasn’t received FDA approval, or hasn’t been in the market long enough to establish a proven track record. In the other corner, you have the large-cap companies with established reputations and steady revenue streams. The former group is speculative, while the latter is more stable.

This gulf between the startups and established names has widened further due to the flurry of IPOs that have entered the biotech market in the past two years. So, it’s important that any index tracking the biotech industry be market-weighted to acknowledge the difference between the startup companies that don’t yet have stable revenue streams and the long-standing larger companies that do. But as Nasdaq Investment Intelligence senior index specialist Mark Marex notes, the S&P Biotechnology Select Industry Index doesn’t acknowledge this disparity through its equal-weighted approach.

“There’s this dichotomy within the industry,” said Marex, adding: “There’s a different level of risk and return with the larger names, so if you want to be properly benchmarking the industry, there’s no reason to be weighting those names equally with the speculative small-cap names.”

While the S&P’s biotech index isn’t cap-weighted, the Nasdaq Biotechnology Index uses a modified cap-weighted methodology composed of securities of Nasdaq-listed companies classified as either biotechnology or pharmaceuticals.

The Nasdaq Biotech Index has included many new biotech names with greater exposure to small- and mid-cap names, but the benchmark is still heavily weighted toward more established names. The top 10 largest components still represent nearly half of the overall index weight after dipping from 50.4% pre-reconstitution to 46.8% immediately after.

According to Marex, this cap-weighted methodology makes more sense. “If you want benchmark exposure in a sector like finance, you want more of your exposure to J.P. Morgan and Goldman Sachs than Main Street Bank of Oregon. That’s a natural, logical approach,” Marex said.

While Marex acknowledges that some investors do want to be speculative, ultimately, he doesn’t see that as being what most investors are looking for when seeking benchmark exposure within the biotech industry.

“It just doesn’t make any sense for an industry that’s been around for four decades,” Marex added.

ETFs that track the NBI include the Invesco Nasdaq Biotechnology ETF (IBBQ A-), the ProShares Ultra Nasdaq Biotechnology ETF (BIB B+), and the *ProShares UltraShort Nasdaq Biotechnology ETF (BIS B+).

For more news, information, and strategy, visit the Nasdaq Investment Intelligence Channel.

Loading Articles...
Help & Info
  • Contact Us
Tools
  • ETF Screener
  • ETF Analyzer
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Performance Visualizer
  • ETF Database Model Portfolios
  • ETF Database Realtime Ratings
  • ETF Database Pro
More Tools
  • ETF Launch Center
  • Financial Advisor & RIA Center
  • ETF Database RSS Feed
Explore ETFs
  • ETF News
  • ETF Picks of the Month
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Best ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Legal
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.
Follow ETF Database
Follow ETF Database

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X